TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CRLBF

Cresco Labs Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

0.63$ -6.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Cresco Labs Inc. (CRLBF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 173 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CRLBF
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
191 188 184 184 180 176 166 164 165 162 151 173 651
97 92 92 90 86 92 87 80 86 78 76 86 326
94 96 92 95 93 84 79 83 79 83 75 87 325
72 69 63 62 65 42 65 58 59 65 64 74 262
169 161 155 152 151 156 152 138 145 144 140 160 589
22 27 29 32 29 20 14 25 20 18 11 13 62
15 15 15 15 16 14 16 14 15 16 15 16 62
-119 13 16 -41 11 3.1 -0.9 2.7 -10 -87 -2.8 -3.6 -104
-116 2.6 -5.2 -54 -11 -4.4 -14 -16 -17 -88 -13 17 -101
– – – – – – – 31 20 -59 27 27 14

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?